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Abstract
American trypanosomiasis or Chagas disease is caused by the protozoan Trypanosoma 
cruzi, which affects a wide variety of hosts including the man, until now treatment options 
or vaccines developed are not enough to control or prevent infected cases. The main way 
of transmission is vectorial, through insects of the Reduviidae family, as well by congenital 
transmission, blood/organ transplants or oral transmission. Chagas disease are considered 
as endemic in many areas due to the presence and lack of control of insect vectors. Many 
touristic places in Latin America are located in endemic areas; however, there is a nonex-
istence of knowledge by touristic service providers about the theme. For that reason, there 
is a latent risk that tourists who come to vacation in endemic areas are exposed get the 
infection. The risk factors are well identified, and this allows that well-defined prevention 
strategies can be established in order to avoid the presentation of cases in visitors to the 
tourist zones. This chapter aimed to describe the situation of Chagas disease in touristic 
areas of the Caribbean of America Latina as and to provide a brief review of information 
that allows visitors to know about the epidemiology and potential risks of this infection.
Keywords: American trypanosomiasis, tourism, endemic regions, vector transmission, 
Mexico
1. Introduction
Nowadays, any destination can be reached from any other place around the world in 36 h 
of travel or less. This 36-h window fits well within the incubation period of most diseases, 
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affording ample opportunity for the unrecognized pathogen movement from place to place 
and for rapid global spread of microbial agents [1].
There are nearly 20 million seropositive persons with Chagas disease (CD) in the Americas, and 90 
million persons, or about one-fifth of Latin America’s population, are at risk of contract Trypanosoma 
cruzi (T. cruzi) infection [2]. The protozoan, known as the causative agent of CD, a neglected tropi-
cal disease, extends through North, Central, and South America, affecting 21 countries [3], with 
over eight million people across Mexico and Central and South America. In the United States, 
around 300,000 to over 1 million people are infected, mostly because of traveling and migration to 
Chagas disease-endemic regions (Figure 1) [5]. This disease has caused more deaths from parasitic 
disorders than from any other parasitic disease in Latin America and was responsible for the third 
highest number of parasitic infections in the world following malaria and schistosomiasis [6].
2. Presence of Chagas disease in the Yucatan Peninsula
Chagas disease transmission has been reported in the Yucatan Peninsula as early as 1941, but 
current information on its incidence is probably underestimated. Mexico is a leader in Latin 
American tourism, and the Yucatan Peninsula is one of the most important tourism destina-
tions in Mexico; it has emerged as a major tourist destination for archeology, weddings and 
romance, rest, parties (spring breakers), ecotourism, diving in subterraneous rivers in caves 
and cenotes, over the past several decades. Tourism numbers have increased during 2017 
over 1,652,653 arrivals each year, that is, over 0.6% from previous years. As in January 2017, 
Figure 1. Distribution of cases of Trypanosoma cruzi infection, based on official estimates and status of vector transmission, 
2006–2009 [4].
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the arrival of foreign air-coming visitors who reside in the United States represented 52.5% 
of all foreign arrivals, followed by Canada as 18.7% and other Latin American and Caribbean 
countries as Argentina and Colombia with 3.3 and 2.3% of total visitors, respectively [7].
Dumonteil and Goubrière [8] constructed a risk map for the natural transmission of Chagas 
disease in the Yucatan peninsula of Mexico, using geographic information systems to design 
predictive models of reduviid abundance (T. dimidiata) and infection rates. They described that 
there were (a) greater numbers of T. dimidiata in warmer and drier climates of the Yucatan, 
including coastal tourist areas; (b) higher reduviid infection rates in areas with lower tempera-
tures and higher precipitation rates, specifically rain forests; and (c) greater reduviid abundance 
in areas of “perturbed” vegetation, defined in their study as agricultural fields and pastures.
In a study conducted by Reyes-Novelo [9], houses of a rural community in Yucatan were 
studied to identify intra or peridomiciliary infestation with T. dimidiate. It was found that 
76.5% of the houses were infested, of those 27.7% colonized and 75% had infected triatomines, 
indicating that both habitats may contribute as sources of T. dimidiata house infestation.
2.1. Risk of travel
Travelers not only put themselves at risk by visiting areas where diseases are emerging, but 
they also run the risk of exposure to disease they do not usually encounter at home. After 
exposure, they may not manifest symptoms due to incubation period, until they return to 
their countries, risking the potential for spread of microbes to new areas [1]. Chagas disease is 
an autochthonous disease of many countries of the western hemisphere, travelers, including 
immigrants have been considered a potential source of introduction of diseases, and CD can 
pose increasing communicable disease risks to travelers in endemic regions of the Americas, 
including beachside resort regions and interior rural regions [2, 10].
The touristic areas in the Yucatan peninsula include coasts, colonial cities and Mayan ruins, 
most of them located in perturbed forested areas, and they are among the most scenic and 
popular destinations for historians, archeologists, ecotourists and cruise line passengers. The 
urban areas in the Yucatan Peninsula had/have a big rate of growing due to the migration 
even from other states of Mexico (caused by the insecurity levels in other states of the country) 
as well the presence of many other citizens coming mainly from Venezuela and Argentina. 
Therefore, many areas from the Yucatan Peninsula are still high-risk regions for Chagas disease 
and are the most frequently visited areas throughout the year by travelers, including Quintana 
Roo (where Cancun and Playa del Carmen are located) Campeche and Yucatan [8].
Human seroprevalence has been reported since the 1970s with a 11.2–18.8% prevalence infec-
tion, and more recent further studies have shown a prevalence in Mayan communities rang-
ing from 1 to 4%, being similar in the city, over 0.6 and 1.7% in blood donors [11, 12].
Over the years, T. cruzi seroprevalence has been reported in several ways, and many popu-
lation groups, which help us, have a general panorama of the situation represented in the 
Yucatan Peninsula. The few studies conducted in the region show the urban and rural preva-
lence that has changed among years, not differing much from each other, pointing out Chagas 
Disease its present, especially in cardiopathic patients, pregnant women and any population 
group, even domestic animals, such as cats and dogs, which humans generally coexist with. 
Seroprevalence found in diverse studies is shown in Table 1.
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A big number of tourists from non-endemic countries can become infected through the skin or 
mucous contact with the stool or urine of infected bloodsucking insects of the triatomine spe-
cies when they visited endemic areas, were exposed, and almost never had previous knowledge 
about the pathogen or the Chagas disease. The acute phase is usually not diagnosed because 
it is characterized by an influenza-like illness acutely in adults. However, as T. cruzi can be 
presented in the blood of infected individuals, decades after infection took place; the infection 
can be also transmitted through blood transfusion and organ transplant, which is considered 
the second most common mode of transmission for T. cruzi. Indeterminate and chronic infec-
tions may be reactivated by immunosuppression, particularly human immunodeficiency virus 
(HIV) infection or acquired immunodeficiency syndrome (AIDS), and by pregnancy [23, 24].
On the acute infection, symptoms are suggestive of a nonspecific febrile illness, and these 
may occur between 1 and 4 weeks after infection; there also are severe forms that include 
myocarditis or meningoencephalitis, chagomas are indurated areas of erythema and swelling 
at the site of parasite penetration. Romaña’s sign is the classic sign of acute Chagas disease; it 
is characterized by painless edema of the palpebrae and periocular tissues that appear when 
the conjunctiva was the parasites route of entry; not all patients with acute Chagas disease 
present with Romaña’s sign (Figure 2) [26].
Immunocompromised travelers, such as advanced aged and people with chronic diseases, 
need to be concerned by their travel physicians of the potential risk for Chagas disease trans-
mission by American Triatomines, due to coasts, colonial cities and ancient archeological 
ruins from Latin America are high endemic regions among the most popular touristic destina-
tion, these patients must be advised about the behavioral risk factors of the disease and take 
the appropriate steps to reduce risk [2, 27].
Study group Area development Seroprevalence (%) Reference
Pregnant women Rural 4.4 Gamboa-Leon et al. [11]
Mothers and newborns Urban 0.8–1.2 Gamboa Leon et al. [13]
General Rural 11.2 Zavala-Veláquez [12]
Pregnant women Rural and urban 0.8 Sosa-Estrani et al. [14]
General Rural and urban 3.7 Nouvellet et al. [15]
General Rural 2.3 Monteon et al. [16]
Cardiopathics Urban 15 Alducin-Tellez et al. [17]
General Urban 8 Jiménez-Coello et al. [18]
Cardiopathics Rural 4.8 Monteón et al. [19]
Other factors
Dogs Rural and urban 14.76 López-Céspedes et al. [20]
Dogs Rural 29.9 Carrillo-Peraza et al. [21]
Cats Urban 8.6 Jiménez-Coello et al. [22]
Data are obtained from [11–22].
Table 1. Prevalence reported in the Yucatan Peninsula.
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Muñoz-Vilches et al. [28] recommended that tourists who travel for long periods through the 
tropics (endemic areas)—like the Yucatan Peninsula—are at risk for acquiring these endemic 
tropical diseases and should be screened similar to patients born in these areas, especially 
when they are symptomatic. Animals can also increase the risk of infection, acting as inter-
mediate hosts of infection; the prevalence of stray dogs nearby plays an important role in CD 
prevalence of endemic places, such as Yucatan [29].
2.2. Presence of vectors
Natural landscapes of the Yucatan Peninsula (YP) have been modified since the expansion of 
Mayan groups at least until 900 A.D., and subsequently the Spanish conquest, mainly in the 
north and east region between Yucatan and Quintana Roo state [30].
Mexico is located in both the neotropical and Nearctic regions, having different demography, 
climates and vegetation, with over 19 vector species, Yucatan has the Triatoma dimidiata as its 
most abundant and epidemiologically relevant vector (Figure 3), although other triatomines 
are present and sporadically collected even in anthropic habitats: Panstrongylus rufotuberculatus, 
Eratyrus cuspidatus, Triatoma nitida, Triatoma hegneri with 88% of the population exposed to at 
least one of this competent vector species [31].
Figure 2. Romaña’s sign and characteristic sign of acute Chagas disease [25].
Figure 3. Triatoma dimidiata [25].
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Previous reports show that there is a heterogenic distribution of the vector, identifying the north 
of the peninsula as the highest bug abundance area and a greater risk of natural transmission [8].
T. cruzi reduviids are hardy and ubiquitous vectors of Chagas disease among wild and domes-
tic animals and humans in a variety of transmission cycles, from dense rain forest to packed 
cities and beaches [2]. The vector adapts quickly to houses, gardens and parks in the city and 
can spread quickly when urbanization is introduced in rural areas. The blood of dogs may 
be an important source of triatomine bugs and acts as sentinels of domestic and peridomestic 
vector-mediated transmission [32].
T. cruzi reduviids are recognized to be sylvatic, periurban and now urban agents of transmis-
sion cycles of Chagas disease; in the sylvatic cycle, the vector becomes infected with T. cruzi as 
either nymphs (the five juvenile stages or instars) or adults during rainy seasons by feeding 
on many nonspecific wild animal hosts. As humans begin to deforest and develop rural areas 
for agriculture, ranching, and housing, infected reduviids are attracted to more stable, perido-
mestic environments. Most often, the pathogenic agents are within the vector’s saliva injected 
directly into the skin, but the metacyclic trypomastigotes of American trypanosomiasis, in 
contrast, are passed not in the saliva, but in the feces of their triatomine vectors. The host is 
infected when these protozoa are scratched or rubbed into the wound or mucus membranes. 
Triatomine bugs of tropical and subtropical Central and South America serve as vectors for 
the agent of Chagas Disease, and these burden people with more than their bites, as with 
bedbugs, conceal themselves during the day, often in thatched roofs and porous walls of logs 
and sticks, and glide down from roof crevices and cracked walls seeking blood from almost 
any available warm-blooded host at night, passing the infectious forms in their feces while 
feeding painlessly [33]. In heavily infested areas, residents may suffer dozens of bites each 
night, with individual adult bugs drawing up to 4 g of blood per meal (Figure 4).
2.3. Preventive recommendations
Travelers in endemic regions are wise to select accommodations with solid ceilings or roofs, 
no thatched palmetto or palm fronds which are the natural canopy homes for reduviids and 
with smooth walls without crevices. Cabanas and lodges that provide accommodations in 
rural or isolated settings for large numbers of tourists are also perfect accommodations for 
reduviid families, who will both blood-feed and breed while hiding in such dwellings, some 
of which may be very comfortable and elegant [34].
As clinicians usually consider, evaluate and recommend prophylactic treatments, vaccines and 
other travel-related issues, they must offer appropriate guidance on preventing vector borne ill-
nesses they might encounter and their arthropods, focusing on their destinations, accommoda-
tions and the risks accompanying their planned activities.
Diaz [2] and Carter et al. [26] mentioned that the best preventive strategies of travelers to the 
Americas should be directed at (1) information about T. cruzi endemic areas and about the 
transmission risks of Chagas disease, (2) avoid residence in poorly constructed dwellings, (3) 
be advised to take precautions while engaging in outdoor activities, and (4) a recommendation 
for sleeping under pyrethroid-impregnated insect nets (taking care of tucking in the edges to 
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provide a physical barrier to the triatomine bugs). However, pyrethroid impregnated nets are 
not definitive or efficient, enough to avoid the insect nearby; also the exposition to chemical 
agents is not recommendable, mainly if their effect over the triatomines is not adequate.
Infection prevention requires travelers to avoid sleeping in hovels and mud dwells and check-
ing in their hotel rooms and potential places where the triatomine vector could be hidden, 
using bed nets, and avoid potentially contaminated fruit or cane juices from street vendors 
[35]. Packing efficient insect repellents and properly applying them, if not purchasing them 
on the destination is an option, always keeping in mind that formulations based on DEET 
remain as the best available repellents, other methods as clothing cleaning with permethrin 
should be considered, clothing is more protective if it has a tight weave and it is loose and 
baggy. Window screens, bed nets and air conditioning can markedly reduce annoyance and 
risk from those biting insects that live or venture indoors [36].
Figure 4. Natural transmission risk map for Chagas disease. The risk of natural transmission of Chagas disease, defined 
as proportional to the abundance of infected Triatoma dimidiata [25].
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The riskier blood or organ donors are those who come from areas where the prevalence of infec-
tion is high; there is also an increased risk in places with a great number of immigrants from 
Mexico, Chile, El Salvador, Colombia, Bolivia, and other Latin American countries. The most 
effective form of prevention is to avoid blood use from donors of countries where Chagas disease 
is endemic, or performing serological screening for T. cruzi exclusively on donors from these 
countries [37].
This lack of knowledge and awareness of Chagas disease and its relationship with triatomines 
can be considered a major barrier for vector control, as it likely results in communities having 
limited interest in and motivation for eliminating triatomines [38].
Concrete recommendations for preventive actions are needed for the national and interna-
tional visitors from endemic and non-endemic countries, focusing on vector control, spread-
ing information and screening in health procedures, all of this should be following a structure 
as listed:
1. Tourism providers and local government from traveler’s country of origin must inform about 
the Chagas disease in this area, its changing nature of ecology, of where no formal measures 
to control or eradicate it have been taken.
2. Protect yourself and your pets from the vector, as they are also warm-blooded hosts and 
sentinels of this disease, they should be required to have a good insecticide or repellent.
3. Hotels and resorts should also have their own vector control plan, as they do with mosqui-
toes and other insects, keeping their green areas clean and not having palm roofs or other 
cracks and holes that could lead to unwanted triatomines.
4. Touristic areas such as ruins, colonial cities and other attractions in endemic zones must be 
fumigated regularly, as a control for the vector, which could be easily attacked.
5. If receiving medical attention, particularly blood transfusions after an accident, labor or 
any other conditions, screening for Chagas Disease is important, due to lots of donors 
could have been previously exposed, have history of CD or the receiver is a female on 
reproductive age, with a higher risk of vertical transmission.
Providing acute information and taking the corresponding recommendations could allow 
reduce the travel-associated risks of Chagas disease infections in this T cruzi endemic region 
from southern of Mexico, and where the CD which is now extended and widely stablished as 
well in urban and rural areas.
3. Conclusions
Chagas disease is as a neglected tropical disease that must be considered by people will-
ing to travel to endemic zones, such as the Yucatan Peninsula. Travelers must be aware of 
the potential risk that exist in the areas they will be interacting in, such as public or resort 
beaches, archeological places, parks, rural areas and even yards; it is crucial for everyone 
traveling to correctly identify the vector, and to use properly insecticides to prevent the 
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triatomines bite and probably infection. However, information about this and other vector 
transmitted diseases must be displayed in the touristic areas and written information given 
to everyone upon arriving, and tourists should take preventive measures such as a good 
quality repellent, checking window screens, holes or other places where the reduviids could 
hide and request bed nets that could be offered by the hosting accommodations, including 
hotels, archeological sites and ecotourism locations. Other measures can be also taken, as 
reduction of the stray dog population, limiting contact with them, and green areas fumiga-
tion for vector control; even when staying in previously fumigated areas, insecticides should 
be used, especially in exterior areas, when walking and even resting on the beach, but one 
of the most important things is to correctly identify the reduviid vector, so travelers can stay 
away from them.
Latin American immigrants represent an important segment in worldwide population; there-
fore, they must consider risks when arriving from their native countries and never lose sight 
of other forms of infection blood transmission possibilities, especially in immune-depressed 
patients and vertical transmission that is taking more importance nowadays.
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